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ABSTRACT The emergence of pan-resistant Klebsiella pneumoniae strains is an in-
creasing concern. In the present study, we describe a cluster of 9 pan-resistant K.
pneumoniae sequence type 147 (ST147) isolates encountered in 4 patients over
nearly 1 year in 3 hospitals of the United Arab Emirates (UAE). The isolates exhibited
highly similar genotypes. All produced chromosomally encoded OXA-181, and the
majority also produced the NDM-5 carbapenemase. As with the previously described
single isolate from the UAE, MS6671, the mgrB was disrupted by a functional, ISEcp1-
driven blaOXA-181 insertion causing resistance to carbapenems. The mutation was
successfully complemented with an intact mgrB gene, indicating that it was respon-
sible for colistin resistance. blaNDM-5 was located within a resistance island of an ap-
proximately 100-kb IncFII plasmid carrying ermB, mph(A), blaTEM-1B, rmtB, blaNDM-5,
sul1, aadA2, and dfrA12 resistance genes. Sequencing this plasmid (pABC143-NDM)
revealed that its backbone was nearly identical to that of plasmid pMS6671E from
which several resistance genes, including blaNDM-5, had been deleted. More exten-
sive similarities of the backbone and the resistance island were found between
pABC143C-NDM and the blaNDM-5-carrying IncFII plasmids of two K. pneumoniae
ST147 isolates from South Korea, one of which was colistin resistant, and both also
produced OXA-181. Notably, one of these strains was isolated from a patient trans-
ferred from the UAE. Our data show that this pan-resistant clone has an alarming ca-
pacity to maintain itself over an extended period of time and is even likely to be
transmitted internationally.
KEYWORDS pan-resistance, Klebsiella pneumoniae, carbapenems, colistin
Klebsiella pneumoniae has long been recognized to cause severe community orhospital-acquired infections (1, 2) and also to gain resistance relatively easily to
multiple antibiotics (2, 3). Certain clones (e.g., clonal complex [CC] 258 or sequence type
[ST] 147) are particularly important in disseminating multidrug resistance globally,
including to carbapenems. Resistance to these later drugs is commonly due to the
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production of various carbapenemases, such as KPC, NDM, VIM, and various alleles of
OXA-type enzymes (3–6).
Management of infections caused by carbapenem-resistant K. pneumoniae often
includes polymyxins, typically colistin (7). Over the last decades, strains with decreased
susceptibility to polymyxins have started to emerge (8). Colistin resistance is commonly
due to the altered physicochemical features of the bacterial cell wall that limit the
capacity of the cationic polymyxin molecules to bind to it. This can be the result of
mutations in several chromosomal genes, of which the most common is mgrB (9).
Recently, genes responsible for colistin resistance located on mobile genetic elements
have also been described, further increasing the chance to spread resistance to
polymyxins (10).
Although the lack of susceptibility to polymyxins in carbapenem-resistant strains
does not mean resistance to all antibiotics, per se, it carries an increased risk of the
emergence of pan-drug-resistant (PDR) clones. Indeed, several PDR K. pneumoniae
strains, some even causing outbreaks, have already been described (11, 12).
In the present study, we report on a cluster of NDM-5- and OXA-181-producing,
pan-resistant K. pneumoniae ST147 strains encountered in two emirates of the United
Arab Emirates (UAE) over a period of 1 year, with possible connections to strains
subsequently isolated in South Korea. Furthermore, we also provide evidence that the
molecular basis of colistin resistance in the cluster was due to the insertion of a
functional blaOXA-181 gene into mgrB.
(Part of this work was presented at the 26th European Congress of Clinical Micro-
biology and Infectious Diseases, 2016, Amsterdam, the Netherlands.)
RESULTS
Collection of strains. In May 2013, four K. pneumoniae isolates (ABC143A to -D)
were received for molecular typing. They were recovered from various samples from
the same patient in an Abu Dhabi hospital (AD hospital) and were resistant to all
antibiotics tested by the hospital laboratory. The patient, who had peritonitis from a
leaking anastomosis after an operation for obstruction and perforation of the small
intestine, had been transferred from an Umm Al Quwain hospital (UAQ hospital A). A
week later another pan-resistant isolate (ABC146) was obtained from the same Abu
Dhabi hospital, this one recovered from the sputum of a 75-year-old male patient
treated during the same period of time, in the same ward. In late May, two more
isolates were recovered from the ﬁrst patient’s blood and peritoneal aspirate (ABC143E
and ABC143F).
In August, a PDR strain from UAQ hospital A, i.e., the same hospital from which the
ﬁrst patient had been transferred to Abu Dhabi, was sent to our laboratory. Strain
ABC164 was isolated from a sample taken from the mastectomy wound of a 75-year-
old, septic, ventilated female patient with advanced breast cancer. According to the
hospital records, all three patients succumbed due to sepsis.
We compared these isolates to another PDR K. pneumoniae strain (MS6671) de-
scribed earlier (12) from a different hospital at Um al Quwain, i.e., UAQ hospital B; this
strain was isolated 7 months after the ﬁrst isolate in UAQ hospital A had been
encountered. The characteristics of the isolates are shown in Table 1.
Antibiotic susceptibility. All strains exhibited nonsusceptibility to all antibiotics
tested, including colistin, fosfomycin, and tigecycline. The MICs of benzalkonium and
irgasan for the strains were similar to the MICs for the Escherichia coli K-12 laboratory
strain; however, the chlorhexidine MICs for the clinical isolates were considerably
higher (Table 2).
Molecular characterization. The isolates from the AD hospital and from UAQ
hospital A clustered by both repetitive elements PCR (rep-PCR; DiversiLab, bioMérieux)
and pulsed-ﬁeld gel electrophoresis (PFGE). Although K. pneumoniae MS6671 exhibited
a considerably different pattern by rep-PCR, its PFGE pattern was still 80% similar to
the PFGE patterns of the K. pneumoniae isolated from the other 3 patients (Fig. 1). All
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isolates tested belonged to ST147. The genotypes of the strains were also highly similar
(Table 1).
All strains carried both blaOXA-181 and blaNDM-5 carbapenemase genes, with the
exception of MS6671 and one isolate (ABC143F) from the ﬁrst patient, which were
positive for blaOXA-181 only. By hybridization, the blaNDM-5 gene could be located on an
approximately 100-kb plasmid, but the OXA-181 probe did not hybridize with any of
the plasmids (data not shown). On the other hand, hybridization of the XbaI-digested
and PFGE-separated full genome of the strains with an OXA-181 probe revealed 3
bands of the same sizes as those seen in MS6671, reported to carry three chromosomal
copies of blaOXA-181 (12). One isolate from the ﬁrst patient (ABC143F) also exhibited an
additional, fourth, smaller fragment hybridizing with the OXA probe (Fig. 2).
PCR of themgrB gene of all isolates resulted in an approximately 3,000-bp amplicon,
suggesting a large insertion into the gene. Sequencing of the amplicons from all nine
isolates revealed an ISEcp1-associated blaOXA-181 gene inserted into the mgrB (Fig. 3). In
order to prove the functionality of the inserted carbapenemase gene, the entire
mgrB::blaOXA-181 amplicons from ABC143C and MS6671 were cloned into pUC19, re-
sulting in plasmids pCoxABC143C and pCoxMS6671. These plasmids were transformed
into E. coli DH5. The transformants exhibited ertapenem and meropenem resistance
TABLE 1 Characteristics of the pan-drug-resistant K. pneumoniae isolates
Isolate
Hospital of
isolation Specimen
Date of
isolation Virulence factor genes Resistance genesa
ABC143A Abu Dhabi hospital Body ﬂuid 12 May 2013 ﬁmH, traT, ureA, uge,
wabG, mrkD, fyuA
blaNDM-5, blaTEM-1B, rmtB, rmtF, blaSHV-36, blaCTX-M-15,
blaOXA-181, aac6=-1b-cr, qacE, cepA
ABC143B Abu Dhabi hospital Sputum 11 May 2013 ﬁmH, traT, ureA, uge,
wabG, mrkD, fyuA
blaNDM-5, blaTEM-1B, rmtB, rmtF, blaSHV-36, blaCTX-M-15,
blaOXA-181, aac6=-1b-cr, qacE, cepA
ABC143C Abu Dhabi hospital Blood 12 May 2013 ﬁmH, traT, ureA, uge,
wabG, mrkD, fyuA
blaNDM-5, blaTEM-1B, rmtB, rmtF, blaSHV-36, blaCTX-M-15,
blaOXA-181, aac6=-1b-cr, qacE, cepA
ABC143D Abu Dhabi hospital Perianal swab 11 May 2013 ﬁmH, traT, ureA, uge,
wabG, mrkD, fyuA
blaNDM-5, blaTEM-1B, rmtB, rmtF, blaSHV-36, blaCTX-M-15,
blaOXA-181, aac6=-1b-cr, qacE, cepA
ABC143E Abu Dhabi hospital Blood 29 May 2013 ﬁmH, traT, ureA, uge,
wabG, mrkD, fyuA
blaNDM-5, blaTEM-1B, blaSHV-36, blaCTX-M-15, blaOXA-181,
rmtF, aac6=-1b-cr, qacE, cepA
ABC143F Abu Dhabi hospital Body ﬂuid 29 May 2013 ﬁmH, traT, ureA, uge,
wabG, mrkD, fyuA
blaTEM-1B, blaSHV-36, blaCTX-M-15, blaOXA-181, rmtF,
aac6=-1b-cr, cepA
ABC146 Abu Dhabi hospital Sputum 21 May 2013 ﬁmH, traT, ureA, uge,
wabG, mrkD, fyuA
blaNDM-5, blaTEM-1B, rmtB, rmtF, blaSHV-36, blaCTX-M-15,
blaOXA-181, aac6=-1b-cr, qacE, cepA
ABC164 Um al Quwain
hospital A
Pus 18 August 2013 ﬁmH, traT, ureA, uge,
wabG, mrkD, fyuA
blaNDM-5, blaTEM-1B, rmtB, rmtF, blaCTX-M-15, blaOXA-181,
aac6=-1b-cr, qacE, cepA
MS6671b Um al Quwain
hospital B
Urine 26 March 2014 ﬁmH, traT, ureA, uge,
wabG, mrkD, fyuA
blaSHV-36, blaCTX-M-15, blaOXA-181, aac6=-1b-cr, cepA,
rmtF
aAs detected by PCR ampliﬁcation and sequencing. The genes in bold were also detected in the pABC143C-NDM complete sequence by next-generation sequencing.
bSee reference 12.
TABLE 2 Antibiotic and disinfectant susceptibility of pan-drug-resistant K. pneumoniae isolates and the transconjugant
Strain
MIC (mg/liter)a
IMI MEM ERT CAZ CTX AZT CIP GM AM SXT TIG FOS COL BAC IRG CHX
ABC143A 128 128 64 128 128 128 64 256 256 256/4864 8 128 16 128 1 32
ABC143B 128 128 64 128 128 128 64 256 256 256/4864 2 128 8 64 0.5 32
ABC143C 128 128 64 128 128 128 64 256 256 256/4864 2 128 8 64 0.5 32
ABC143D 128 128 64 128 128 128 64 256 256 256/4864 4 128 8 64 1 32
ABC143E 128 128 64 128 128 128 64 256 256 256/4864 4 64 256 64 0.5 32
ABC143F 16 32 64 32 128 128 64 256 256 4/76 8 256 4 64 0.5 16
ABC146 16 128 64 128 128 128 64 256 256 256/4864 2 64 8 64 0.5 32
ABC164 128 128 64 128 128 128 64 256 256 256/4864 2 64 32 64 0.5 32
MS6671 16 128 64 64 128 128 64 256 256 8/152 2 64 32 64 1 32
J53RAZ(pABC143C/1) 4 16 8 128 64 0.25 0.125 256 256 0.5/9.5 0.125 1 0.5 128 0.5 2
J53RAZ 0.25 0.25 0.125 0.25 0.25 0.25 0.125 0.5 0.5 0.5/9.5 0.125 1 0.5 128 0.5 2
aIMI, imipenem; MEM, meropenem; ETP, ertapenem; CAZ, ceftazidime; CTX, cefotaxime; AZT, aztreonam; CIP, ciproﬂoxacin; GM, gentamicin; AM, amikacin; SXT,
trimethoprim-sulfamethoxazole; TIG, tigecycline; COL, colistin; FOS, fosfomycin; BAC, benzalkonium; IRG, irgasan; CHX, chlorhexidine.
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while maintaining susceptibility to ceftazidime, cefotaxime, and aztreonam, respec-
tively, suggestive of a functional OXA-181 carbapenemase (Table 3).
The effect of the mgrB::blaOXA-181 insertion on the strains’ susceptibility to colistin
was successfully reversed by introducing pComgrB, i.e., the pDG106 vector carrying an
intact mgrB gene. Both ABC143C(pComgrB) and MS6671(pComgrB) regained their suscep-
tibility to colistin, while the transformants carrying the vector only did not (Table 4).
Plasmid pABC143C-NDM carrying the blaNDM-5 gene.We obtained the complete
sequence of the plasmid present in most strains of the cluster carrying the blaNDM-5
gene from K. pneumoniae ABC143C. pABC143C-NDM (GenBank accession no.
KY130431) is an IncFII incompatibility type plasmid of 96,549 bp with a GC content of
52.8%. It has 119 coding sequences, of which eight encode antibiotic resistance: ermB,
mph(A), blaTEM-1B, rmtB, blaNDM-5, sul1, aadA2, and dfrA12 (Fig. 4). These genes are
located in a resistance island inserted into the 66,915-bp-long plasmid backbone, which
is highly similar to that of plasmid pMS6671E of MS6671 (GenBank accession no.
LN824138), i.e., the blaNDM-negative strain recovered in UAQ hospital B (12). Even more
similarities were revealed with two other IncFII-type plasmids, both carrying blaNDM-5,
i.e., pCC1410-1 and pCC1409-1 (GenBank accession no. KT725788 and KT725789,
respectively) from strains isolated in South Korea (5, 13). The pMS6671E plasmid carried
FIG 1 Comparative typing of members of the cluster. (A) rep-PCR (DiversiLab); (B) PFGE.
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a resistance island different from those of the other three plasmids, as it did not contain
the ermB, mph(A), blaTEM-1B, rmtB, blaNDM-5, or sul1 genes, although it also harbored the
ltrA gene, which is present in the other Emirati plasmids but notably absent from the
Korean ones. On the other hand, the resistance islands of the three other plasmids
exhibited high levels of similarity, especially in pCC1410-1 and pABC143C-NDM, which
were, with the exception of the presence of ltrA, identical (Fig. 4).
DISCUSSION
Pan-drug-resistant K. pneumoniae infections have been reported since 2005 (14),
and most recently, even clusters or outbreaks caused by the KPC-2 producer K.
pneumoniae ST258 have been recorded (11, 15). In Greece, a single pan-drug-resistant
K. pneumoniae ST147 isolate was also encountered among K. pneumoniae ST258 strains
(11) representing the majority of local pan-drug-resistant isolates. Here, we report on a
cluster of highly similar, pan-drug-resistant K. pneumoniae ST147 strains isolated from
three cases in two emirates of the UAE. The short time between the isolation of strains
from the ﬁrst two patients in the same AD hospital and the association of the ﬁrst
patient with UAQ hospital A, where the third case was identiﬁed, make the connection
likely. Nevertheless, the paucity of epidemiological data prevents us from substantiat-
ing this assumption. We assume that these isolates are also closely related to a
pan-drug-resistant K. pneumoniae ST147 isolate from UAQ hospital B, MS6671, carrying
three chromosomal copies of blaOXA-181 isolated a few months later (12). In addition to
belonging to the same ST and having highly similar genotypes (Table 1) and similarities
in their pulsed-ﬁeld gel electrophoresis (PFGE) patterns (Fig. 1), our isolates also carried
three copies of the OXA gene in fragments of their XbaI-restricted genomes of
molecular masses identical to that of MS6671 (Fig. 2). In one strain, ABC143F, a fourth
fragment of the PFGE pattern was also labeled, suggestive of the presence of another
FIG 2 Hybridization of the genomic DNA fragments of strains with an OXA-181 probe. Samples: 1 and
11, Salmonella enterica serovar Braenderup strain H9812, molecular mass standard; 2, ABC143A; 3,
ABC143B; 4, ABC143C; 5, ABC143D; 6, ABC143E; 7, ABC143F; 8, ABC146; 9, ABC164; 10, MS6671.
FIG 3 Structure of the mgrB::blaOXA-181 insert.
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copy of blaOXA-181. As with isolate MS6671, colistin resistance of the current strains was
also due to an mgrB::blaOXA-181 insertion. Furthermore, the backbone of the blaNDM-5-
containing plasmid pABC143C-NDM exhibited extensive similarities to that of pMS6671E. A
possible explanation for the differences between these two plasmids might be that in
MS6671, a recombination event between the chromosomally located class I integron
and the integron located on the IncFII plasmid took place, resulting in the loss of the
ermB, mph(A), blaTEM-1B, rmtB, blaNDM-5, and sul1 resistance genes. It was noteworthy,
however, that this event, i.e., the loss of blaNDM-5, did not change the susceptibility
proﬁle of K. pneumoniae MS6671, since its remarkable array of resistance genes (12) still
made it pan-resistant. A similar scenario might have occurred in ABC143F, one of the
isolates from the ﬁrst patient, which lost the rmtB and blaNDM-5 genes. However,
investigating this was beyond the scope of the present study.
Plasmid structures highly similar to pABC143C (pCC1410-1 and pCC1409-1 [GenBank
accession no. KT725788 and KT725789]) were previously revealed in two strains isolated
in South Korea (5). Like members of the UAE cluster, they belonged to K. pneumoniae
ST147 and both carried the blaOXA-181 and blaNDM-5 carbapenemases. Notably, the ﬁrst
strain (CC1409-1) was recovered from a patient who had been transferred in 2014 from
an undisclosed hospital in Abu Dhabi to Seoul, South Korea. While CC1409-1 was still
susceptible to colistin, the strain isolated 4 months later in the same hospital
(CC1410-1) was resistant to polymyxins, although the basis of its colistin resistance has
not been disclosed (13). Although these strains were not available to us for a more
detailed comparison, on the basis of all the similarities between their genotypes and
the nearly identical structures of their blaNDM-5-carrying plasmids (Fig. 3), we surmise
that these South Korean strains also closely related to this speciﬁc cluster of K.
pneumoniae ST147 isolates.
Enterobacteriaceae possessing two carbapenemases have previously been observed
worldwide (16) and in the region as well (6, 17, 18). It is of particular concern that
representatives of the K. pneumoniae ST147 clone, well known for its epidemic potential
(4, 6), not only are present in the UAE as dual-carbapenemase-producing isolates but
also develop resistance to the last-resort antibiotic, colistin, by insertion of a functional
carbapenemase gene into themgrB gene. Apart from the earlier report on MS6671 (12),
a similar ISEcp1-driven insertional mutation of mgrB in K. pneumoniae has been ob-
served in a single isolate in France, but in that case, an extended-spectrum beta-
lactamase gene (blaCTX-M-15) was coded on the insertion, and the strain remained
susceptible to an array of antibiotics (19).
It is not known to what extent the reduced susceptibility to chlorhexidine contrib-
TABLE 3 Carbapenemase activity of the mgrB::blaOXA-181 structure cloned from ABC143C
and MS6671
Strain
MIC (mg/liter)a
IMI MEM ERT CAZ CTX AZT
DH5(pUC19) 0.25 0.25 0.125 0.25 0.25 0.25
ABC143C 128 128 64 128 128 128
DH5(pCoxABC143C#13) 1 2 1 0.25 0.25 0.25
MS6671 16 128 64 64 128 128
DH5(pCoxMS6671#6) 1 2 2 0.25 0.25 0.25
aIMI, imipenem; MEM, meropenem; ETP, ertapenem; CAZ, ceftazidime; CTX, cefotaxime; AZT, aztreonam.
TABLE 4 Complementation of the mgrB::blaOXA-181 mutation
Strain MIC of colistin (mg/liter)a
ABC143C(pDG106) 16
ABC143C(pComgrB) 1
MS6671(pDG106) 16
MS6671(pComgrB) 1
aColistin susceptibility tests were carried out in the presence of 100 M HgCl2.
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uted to the spread or reoccurrence of this pan-drug-resistant K. pneumoniae ST147
clone in multiple hospitals. Carrying the cepA and qacE genes has been associated
previously with such a phenotype (20). On the other hand, the insertional mutation
leading to colistin resistance in our study was different from those recently described
in colistin- and chlorhexidine-cross-resistant K. pneumoniae isolates, and the level of
chlorhexidine nonsusceptibility did not reach the levels noted in that study (21).
Important limitations of the study are the lack of available more-detailed epidemi-
ological data revealing the actual links and exploring the possible modes of transmis-
sion between the cases. Furthermore, as currently there are no nationwide antibiotic
surveillance data and the laboratories are under no obligation to submit multidrug-
resistant isolates for molecular typing, it is not known whether the cluster described
represents its real size or additional such isolates are still present in the region.
Nevertheless, our data show that this pan-resistant K. pneumoniae ST147 clone, with
a unique, ISEcp1-directed blaOXA-181 insertion in the mgrB gene, i.e., a single genetic
event causing resistance to two agents used to treat severe Gram-negative infections,
carries a considerable outbreak potential, as evidenced by its repeated occurrence in
multiple hospitals, including possible international spread, over an extended period of
time. Beyond enforced infection control measures, only extensive, national, and region-
wide antimicrobial resistance surveillance with molecular typing investigations may
carry the promise to contain the spread of such strains.
MATERIALS AND METHODS
Bacterial isolates. Strains were submitted to our laboratory for molecular typing according to the
nonmandatory recommendation of the Health Authority Abu Dhabi regarding carbapenem-resistant
Enterobacteriaceae (CRE) isolates. Strains were received with basic demographic and clinical information
only, i.e., strictly without any patient identiﬁers. The isolates were preserved in duplicate at 80°C.
Antimicrobial susceptibility testing. Antibiotic susceptibility was routinely tested by microdilution
according to the CLSI standards (22), while in the case of colistin, tigecycline, and fosfomycin, the EUCAST
guidelines (23) were applied. Agar dilution was used to establish susceptibilities to chlorhexidine,
benzalkonium, and irgasan.
Genotyping. The presence of virulence-related genes magA, allS, mrkD, rmpA, kfuBC, ﬁmH, ureA, uge,
wabG, fyuA, iutA, ireA, iroN, cnf1, traT, and clpK (24, 25), of those determining the capsular types (26), and
of antibiotic and disinfectant resistance genes blaTEM, blaCTX-M, blaSHV, blaPER, blaAmpC, blaNDM, blaOXA-48-like,
FIG 4 Structure of pABC143C. Note that the structures are represented disproportionately to their real size. The GenBank numbers of the plasmids are shown
in parentheses.
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blaKPC, blaVIM, blaIMP, armA, rmtA, rmtB, rmtC, rmtD, rmtE, rmtF, qnrS, qepA, aac6=-1b-cr, emrE, qacDE, qacF,
qacE, mdfA, ydgE, ydgF, sugE(c), sugE(p), and cepA was tested by PCR as previously described (27). The
allele of the OXA-48-like enzyme was determined by direct sequencing of the amplicon containing the
mgrB::blaOXA structure, while that of blaNDM was revealed by PCR and direct sequencing with primers
AS-ndm1 and AS-ndm2 (28).
Molecular typing. Isolates were compared by using rep-PCR (DiversiLab; bioMérieux) and applying
a Klebsiella kit, according to the manufacturer’s recommendation, and by XbaI-restricted genome
digestion followed by pulsed-ﬁeld gel electrophoresis (PFGE), as described previously (29). For hybrid-
ization of the PFGE gel, the amount of bacterial cells for plug preparation was doubled. PFGE patterns
were analyzed with GelCompar II software (Applied Maths, Belgium) and by applying the unweighted
pair group method with arithmetic mean (UPGMA) with the Dice similarity coefﬁcient (SD) with a 1.5%
position tolerance. The sequence type of the isolates was determined by multilocus sequence typing
(MLST) (30) using the MLST webpage http://www.pasteur.fr/recherche/genopole/PF8/mlst/Kpneumoniae
.html.
Plasmid work. Extraction and electrophoresis of the plasmids were carried out by the method of
Kado and Liu (31), using plasmids in E. coli 39R861 and E. coli V517 as molecular mass markers.
From K. pneumoniae ABC143C, the pABC143C-NDM-5 plasmid was transferred by conjugation into E.
coli J53RAZ as described previously (32). From the transconjugant, the plasmid was puriﬁed by using a
plasmid maxiprep kit (Qiagen, Germany), and its complete sequence was determined commercially at the
CCIB DNA Core Facility at Massachusetts General Hospital (Cambridge, MA). PCR mapping and direct
sequencing were used to close the gaps between the contigs and to unambiguously determine the
sequence of the plasmid. Antibiotic resistance genes on the assembled plasmid were identiﬁed by
ResFinder 2.1 (33). The sequences were annotated using Sequin (http://www.ncbi.nlm.nih.gov/Sequin)
and submitted to GenBank. The Inc type of the plasmid was deduced from its complete sequence (34).
Hybridization. Hybridization of the plasmid and PFGE gel transferred to Hybond N (Roche)
membranes was carried out as described previously (32).
Cloning and complementing the mgrB gene with a blaOXA-181 insertion. To PCR clone the entire
mgrB gene, with or without insertion, external primers (8) were used with additional BamHI plus CGCCGC
overhangs. The mgrB::blaOXA-181 structure ampliﬁed was cloned into the BamHI-digested pUC19 and
transformed into E. coli DH5 (28), and transformants were selected on plates containing 2 mg/liter
ertapenem.
To complement the mgrB::blaOXA-181 insertion, an intact mgrB gene was ampliﬁed from ABC193, a
colistin-susceptible K. pneumoniae strain, and cloned into the BamHI site of pDG106, i.e., a vector
containing the mercury resistance merR gene, obtained from the National Institute of Genetics, Japan
(35). This construct was transformed (28) into the colistin-resistant wild-type strains ABC143C and
MS6671, with selection of transformants on plates containing 100 M HgCl2. The colistin susceptibilities
of the transformants were compared to those of similarly prepared derivatives containing the pDG106
vector without the mgrB insert by using serial dilution of colistin sulfate with a constant concentration
of 100 M HgCl2 in order to maintain the plasmid in the derivatives.
Accession number(s). The sequences of the mgrB PCR product of ABC143C and pABC143C-NDM
were deposited in GenBank under accession numbers KY426739 and KY130431, respectively.
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